{"slideshow_credits": null, "snippet": "Douglas M. Lankler, Pfizer&#8217;s chief general counsel, responds to a front-page article.", "abstract": null, "section_name": "Opinion", "print_page": "20", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2014/11/10/opinion/pfizers-missouri-case.html", "lead_paragraph": "Douglas M. Lankler, Pfizer&#8217;s chief general counsel, responds to a front-page article.", "headline": {"main": "Pfizer&#8217;s Missouri Case", "print_headline": "Pfizer\u2019s Missouri Case", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "5460087838f0d873a2dbd352", "word_count": "131", "multimedia": [], "pub_date": "2014-11-10T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Pfizer Inc", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Attorneys General", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Ethics and Official Misconduct", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Missouri", "name": "glocations", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}